Estrogen signaling suppresses tumor-associated tissue eosinophilia to promote breast tumor growth
Science Advances · 2024
DOI: 10.1126/sciadv.adp2442 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Sandeep Artham und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA. Hauptthemen laut MEDLINE: Estrogens, Signal Transduction, Breast Neoplasms, Eosinophils. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Estrogens regulate eosinophilia in asthma and other inflammatory diseases. Further, peripheral eosinophilia and tumor-associated tissue eosinophilia (TATE) predicts a better response to immune checkpoint blockade (ICB) in breast cancer. However, how and if estrogens affect eosinophil biology in tumors and how this influences ICB efficacy has not been determined. Here, we report that estrogens decrease the number of peripheral eosinophils and TATE, and this contributes to increased tumor growth in validated murine models of breast cancer and melanoma. Moreover, estrogen signaling in healthy female mice also suppressed peripheral eosinophil prevalence by decreasing the proliferation and survival of maturing eosinophils. Inhibiting estrogen receptor (ER) signaling decreased tumor growth in an eosinophil-dependent manner. Further, the efficacy of ICBs was increased when administered in combination with anti-estrogens. These findings highlight the importance of ER signaling as a regulator of eosinophil biology and TATE and highlight the potential near-term clinical application of ER modulators to increase ICB efficacy in multiple tumor types.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA.
- Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
- Division of Gastroenterology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
ORCID-Profile: Sandeep Artham, Aditi Goyal, Jovita Byemerwa, Suzanne E Wardell, Binita Chakraborty, Daniel Crowder, Felicia Lim, Corinne H Strawser, Susan Dent, Jatin Roper, Charles M Perou, Ching-Yi Chang, Donald P McDonnell
Förderung
- NCI NIH HHS
Zitieren
APA
Artham, S., Juras, P. K., Goyal, A., Chakraborty, P., Byemerwa, J., Liu, S., Wardell, S. E., Chakraborty, B., Crowder, D., Lim, F., Strawser, C. H., Newlin, M., Racioppi, A., Dent, S., Mirminachi, B., Roper, J., Perou, C. M., Chang, C. Y., & McDonnell, D. P. (2024). Estrogen signaling suppresses tumor-associated tissue eosinophilia to promote breast tumor growth. Science Advances. https://doi.org/10.1126/sciadv.adp2442
Vancouver
Artham S, Juras PK, Goyal A, Chakraborty P, Byemerwa J, Liu S, et al. Estrogen signaling suppresses tumor-associated tissue eosinophilia to promote breast tumor growth. Science Advances. 2024. doi:10.1126/sciadv.adp2442
BibTeX
@article{Artham2024,
author = {Artham, Sandeep and Juras, Patrick K and Goyal, Aditi and Chakraborty, Prabuddha and Byemerwa, Jovita and Liu, Siyao and Wardell, Suzanne E and Chakraborty, Binita and Crowder, Daniel and Lim, Felicia and Strawser, Corinne H and Newlin, Madeline and Racioppi, Alessandro and Dent, Susan and Mirminachi, Babak and Roper, Jatin and Perou, Charles M and Chang, Ching-Yi and McDonnell, Donald P},
title = {Estrogen signaling suppresses tumor-associated tissue eosinophilia to promote breast tumor growth},
journal = {Science Advances},
year = {2024},
doi = {10.1126/sciadv.adp2442}
}
EUVIMED